Labcorp (LH) stock: analyst price target and their real reliability
Live quote · data updated Aug 28, 2026
Labcorp · Health Care · ref. ETF XLV · 50 calls · price $336.54
What the company does: Labcorp Holdings Inc. provides laboratory services. It operates in Diagnostics Laboratories and Biopharma Laboratory Services segments.
📈 Labcorp (LH) stock price
$336.54+22.2% over range
Aug 28, 25low $246.64 · high $339.34Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
75% recommend buying · 8 analysts
📊 JPI status : Labcorp has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
⚠️ The stock trades above the median target: it has beaten expectations. The “Buy” reflects conviction on the company, but the remaining quantified upside is low/negative.
🎯 LH price target & analyst consensus — price $337
The price target · all analysts combined (8 targets)
Highest target · 1 firm of 8$360+7.0%
Median target · of 8 targets$329-2.2%
Lowest target · 1 firm of 8$300-10.9%
Current price$336.54
Where these 8 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
450%
$338 ↔ $360
Below
450%
$300 ↔ $320
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: Morgan Stanley — 69% of its targets hit on this sector (825 calls tested). It aims for $338 (+0.4 %), call made on August 1, 2026, maturing on August 1, 2027 (27 d ago).
The 7 reliable analysts
$338+0.4 %
The 1 other firm
$300-11 %
How to read it: the 7 reliable firms are not filtered by optimism — 4 aim above the price, 3 below, hence their $338 median. “The 1 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 8 ratings (last 6 months)
Strong Buy00%
Buy675%
Hold225%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 LH price target all
All 50 calls, one by one, with our verdict on each firm.
→ See all 50 targets, analyst by analyst💡 The best analysts on LH most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in LH? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Labcorp? The JPI assistant answers using our backtest data.
💰 Labcorp dividend: yield, history & growth › open the full page
1.01%annual yield
That's ~$2.88 per share per year.
📈 Labcorp fundamentals: valuation, margins & growth › open the full page
P/E 27.8Net margin 7.0 %Revenue growth +5.8 %Cheap for the growth
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2022
marg. 9 %
2023
Rev −18%Profit −67%
2024
Rev +7%Profit +78%
2025
Rev +7%Profit +17%
🔎 Detailed analyses
✅ Historical analyst reliability on LH
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| SunTrust Robinson Humphrey | 100% | +56.2% | 3 |
| JP Morgan ↗ | 100% | +33.3% | 5 |
| Citigroup ↗ | 100% | +19.4% | 5 |
| Cantor Fitzgerald ↗ | 100% | +9.2% | 3 |
| UBS ↗ | 90% | +22.2% | 10 |
| Baird ↗ | 86% | +13.9% | 14 |
| Keybanc ↗ | 83% | +23.0% | 6 |
| B of A Securities ↗ | 83% | +17.4% | 6 |
| Truist Securities ↗ | 82% | +7.3% | 11 |
| Wells Fargo ↗ | 71% | +19.8% | 7 |
See the other 10 firms
| Credit Suisse | 44% | -1.4% | 16 |
| Jefferies ↗ | 50% | -2.9% | 4 |
| Goldman Sachs ↗ | 50% | -2.9% | 2 |
| Argus Research ↗ | 50% | +6.1% | 4 |
| Mizuho ↗ | 54% | +5.4% | 13 |
| Evercore ISI Group ↗ | 60% | +0.1% | 5 |
| Canaccord Genuity ↗ | 67% | +3.6% | 6 |
| Barclays ↗ | 67% | +17.1% | 9 |
| Morgan Stanley ↗ | 70% | +9.6% | 23 |
| Deutsche Bank ↗ | 71% | +11.3% | 7 |
📊 What $1,000 invested in Labcorp would be worth › open the full page
In short — $1,000 invested in Labcorp 10 years ago would be worth $2,636 today, i.e. +10%/yr on average. Best year: 2021 (+54%), worst: 2022 (-25%). Price performance, excluding dividends.
If I'd invested $1,000 in Labcorp
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $1,221 | +22% |
| 3 years ago | $1,384 | +38% |
| 5 years ago | $1,601 | +60% |
Return by year (Labcorp)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | +12% | $1,116 (+12%) |
| 2025 | +9% | $1,221 (+22%) |
| 2024 | +1% | $1,232 (+23%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Labcorp
Loading news…
📋 All analyst calls on LH
Filtered on — · ✕ show all
Piper Sandler ↗
Aug 4, 26
■ Neutral neutral · not a buy · 🎯$309
Price at call : $313.96 — gap to target -2%
Today : $336.54 — gap to target -8%
🎯 on LH : no call matured yet · 📊 on Health : 46.7% · -1.3% (321 calls)
in progress (365j)
matures : Aug 4, 27
matures : Aug 4, 27
▲ Overweight · 🎯$360
Price at call : $312.34 — upside +15%
Today : $336.54 — upside +7%
🎯 on LH : no call matured yet · 📊 on Health : 53.8% · +5.3% (355 calls)
in progress (365j)
matures : Aug 3, 27
matures : Aug 3, 27
Morgan Stanley ↗
Jul 31, 26
▲ Overweight · 🎯$338
Price at call : $307.42 — upside +10%
Today : $336.54 — upside +0%
🎯 on LH : 100% (3 calls matureds) · 📊 on Health : 51.5% · +5.2% (825 calls)
in progress (365j)
matures : Jul 31, 27
matures : Jul 31, 27
Truist Securities ↗
Jul 31, 26
▲ Buy · 🎯$350
Price at call : $309.2 — upside +13%
Today : $336.54 — upside +4%
🎯 on LH : 100% (3 calls matureds) · 📊 on Health : 49.6% · +2.3% (260 calls)
in progress (365j)
matures : Jul 31, 27
matures : Jul 31, 27
■ Equal-Weight neutral · not a buy · 🎯$320
Price at call : $309.2 — gap to target +3%
Today : $336.54 — gap to target -5%
🎯 on LH : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Jul 31, 27
matures : Jul 31, 27
B of A Securities ↗
Jul 13, 26
▲ Buy · 🎯$320
Price at call : $275.68 — upside +16%
Today : $336.54 — upside -5%
🎯 on LH : 100% (2 calls matureds) · 📊 on Health : 48.3% · +2.0% (356 calls)
in progress (365j)
matures : Jul 13, 27
matures : Jul 13, 27
▲ Outperform · 🎯$338
Price at call : $275.68 — upside +23%
Today : $336.54 — upside +0%
🎯 on LH : 100% (3 calls matureds) · 📊 on Health : 51.7% · +6.5% (298 calls)
in progress (365j)
matures : Jul 13, 27
matures : Jul 13, 27
Evercore ISI Group ↗
Apr 8, 26
▲ Outperform · 🎯$300
Price at call : $273.26 — upside +10%
Today : $336.54 — upside -11%
🎯 on LH : 100% (3 calls matureds) · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Apr 8, 27
matures : Apr 8, 27
See the other 42 calls, newest to oldest
Piper Sandler ↗
Feb 24, 26
■ Neutral neutral · not a buy · 🎯$300
Price at call : $282.78 — gap to target +6%
Today : $336.54 — gap to target -11%
🎯 on LH : no call matured yet · 📊 on Health : 46.7% · -1.3% (321 calls)
in progress (365j)
matures : Feb 24, 27
matures : Feb 24, 27
▲ Overweight · 🎯$330
Price at call : $282.48 — upside +17%
Today : $336.54 — upside -2%
🎯 on LH : no call matured yet · 📊 on Health : 53.8% · +5.3% (355 calls)
in progress (365j)
matures : Feb 18, 27
matures : Feb 18, 27
▲ Outperform · 🎯$326
Price at call : $278.76 — upside +17%
Today : $336.54 — upside -3%
🎯 on LH : 100% (3 calls matureds) · 📊 on Health : 51.7% · +6.5% (298 calls)
in progress (365j)
matures : Feb 18, 27
matures : Feb 18, 27
▲ Overweight · 🎯$319
Price at call : $274.01 — upside +16%
Today : $336.54 — upside -5%
🎯 on LH : no call matured yet · 📊 on Health : 53.8% · +5.3% (355 calls)
in progress (365j)
matures : Feb 6, 27
matures : Feb 6, 27
▲ Overweight · 🎯$317
Price at call : $261.13 — upside +21%
Today : $336.54 — upside -6%
🎯 on LH : no call matured yet · 📊 on Health : 53.8% · +5.3% (355 calls)
in progress (365j)
matures : Nov 7, 26
matures : Nov 7, 26
▲ Buy · 🎯$320
Price at call : $252.33 — upside +27%
Today : $336.54 — upside -5%
🎯 on LH : 100% (3 calls matureds) · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Oct 29, 26
matures : Oct 29, 26
▲ Buy · 🎯$325
Price at call : $290.93 — upside +12%
Today : $336.54 — upside -3%
🎯 on LH : 100% (3 calls matureds) · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Oct 17, 26
matures : Oct 17, 26
▲ Outperform · 🎯$320
Price at call : $285.94 — upside +12%
Today : $336.54 — upside -5%
🎯 on LH : no call matured yet · 📊 on Health : 52.1% · +3.5% (217 calls)
in progress (365j)
matures : Oct 17, 26
matures : Oct 17, 26
Evercore ISI Group ↗
Oct 3, 25
▲ Outperform · 🎯$305
Price at call : $275.05 — upside +11%
Today : $336.54 — upside -9%
🎯 on LH : 100% (3 calls matureds) · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Oct 3, 26
matures : Oct 3, 26
■ Equal-Weight neutral · not a buy · 🎯$290
Price at call : $276.94 — gap to target +5%
Today : $336.54 — gap to target -14%
🎯 on LH : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Oct 2, 26
matures : Oct 2, 26
Truist Securities ↗
Jul 25, 25
▲ Buy · 🎯$310
Price at call : $261.88 — upside +18%
Today : $336.54 — upside -8%
Expected +18% · Actual +15% · Reason (≥ +15%) : ✓ Yes
🎯 on LH : 100% (3 calls matureds) · 📊 on Health : 49.6% · +2.3% (260 calls)
+15.0%
stock +15% · XLV +21%
matured Jul 25, 26
▲ Buy · 🎯$305
Price at call : $261.88 — upside +16%
Today : $336.54 — upside -9%
Expected +16% · Actual +15% · Reason (≥ +15%) : ✓ Yes
🎯 on LH : 100% (3 calls matureds) · 📊 on Health : 51.5% · +3.1% (355 calls)
+15.0%
stock +15% · XLV +21%
matured Jul 25, 26
Evercore ISI Group ↗
Jul 25, 25
▲ Outperform · 🎯$300
Price at call : $261.88 — upside +15%
Today : $336.54 — upside -11%
Expected +15% · Actual +15% · Reason (≥ +15%) : ✓ Yes
🎯 on LH : 100% (3 calls matureds) · 📊 on Health : 45.8% · +0.0% (168 calls)
+15.0%
stock +15% · XLV +21%
matured Jul 25, 26
Morgan Stanley ↗
Jul 25, 25
▲ Overweight · 🎯$306
Price at call : $264.96 — upside +15%
Today : $336.54 — upside -9%
Expected +15% · Actual +14% · Reason (≥ +15%) : ✗ No
🎯 on LH : 100% (3 calls matureds) · 📊 on Health : 51.5% · +5.2% (825 calls)
+13.7%
stock +14% · XLV +20%
matured Jul 25, 26
▲ Outperform · 🎯$302
Price at call : $264.96 — upside +14%
Today : $336.54 — upside -10%
Expected +14% · Actual +14% · Reason (≥ +15%) : ✗ No
🎯 on LH : 100% (3 calls matureds) · 📊 on Health : 51.7% · +6.5% (298 calls)
+13.7%
stock +14% · XLV +20%
matured Jul 25, 26
▲ Buy · 🎯$282
Price at call : $243.04 — upside +16%
Today : $336.54 — upside -16%
Expected +16% · Actual +16% · Reason (≥ +15%) : ✓ Yes
🎯 on LH : 100% (3 calls matureds) · 📊 on Health : 51.5% · +3.1% (355 calls)
+15.8%
stock +16% · XLV +21%
matured Jul 18, 26
Evercore ISI Group ↗
Jul 9, 25
▲ Outperform · 🎯$285
Price at call : $259.07 — upside +10%
Today : $336.54 — upside -15%
Expected +10% · Actual +7% · Reason (≥ +15%) : ✗ No
🎯 on LH : 100% (3 calls matureds) · 📊 on Health : 45.8% · +0.0% (168 calls)
+7.2%
stock +7% · XLV +20%
matured Jul 9, 26
■ Equal-Weight neutral · not a buy · 🎯$275
Price at call : $256.98 — gap to target +7%
Today : $336.54 — gap to target -18%
🎯 on LH : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Jun 25, 26
matures : Jun 25, 26
Morgan Stanley ↗
Jun 11, 25
▲ Overweight · 🎯$283
Price at call : $261.65 — upside +8%
Today : $336.54 — upside -16%
Expected +8% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on LH : 100% (3 calls matureds) · 📊 on Health : 51.5% · +5.2% (825 calls)
+1.7%
stock +2% · XLV +12%
matured Jun 11, 26
Truist Securities ↗
May 12, 25
▲ Buy · 🎯$290
Price at call : $250.01 — upside +16%
Today : $336.54 — upside -14%
Expected +16% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on LH : 100% (3 calls matureds) · 📊 on Health : 49.6% · +2.3% (260 calls)
+1.8%
stock +2% · XLV +11%
matured May 12, 26
Piper Sandler ↗
May 6, 25
■ Neutral neutral · not a buy · 🎯$280
Price at call : $245.9 — gap to target +14%
Today : $336.54 — gap to target -17%
🎯 on LH : no call matured yet · 📊 on Health : 46.7% · -1.3% (321 calls)
in progress (365j)
matures : May 6, 26
matures : May 6, 26
■ Equal-Weight neutral · not a buy · 🎯$250
Price at call : $241.28 — gap to target +4%
Today : $336.54 — gap to target -26%
🎯 on LH : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : May 1, 26
matures : May 1, 26
▲ Outperform · 🎯$267
Price at call : $241.28 — upside +11%
Today : $336.54 — upside -21%
Expected +11% · Actual +6% · Reason (≥ +15%) : ✗ No
🎯 on LH : 100% (3 calls matureds) · 📊 on Health : 51.7% · +6.5% (298 calls)
+6.0%
stock +6% · XLV +6%
matured Apr 30, 26
Truist Securities ↗
Apr 11, 25
▲ Buy · 🎯$274
Price at call : $221.46 — upside +24%
Today : $336.54 — upside -19%
Expected +24% · Actual +19% · Reason (≥ +15%) : ✓ Yes
🎯 on LH : 100% (3 calls matureds) · 📊 on Health : 49.6% · +2.3% (260 calls)
+19.3%
stock +19% · XLV +8%
matured Apr 11, 26
■ Equal-Weight neutral · not a buy · 🎯$240
Price at call : $221.46 — gap to target +8%
Today : $336.54 — gap to target -29%
🎯 on LH : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Apr 10, 26
matures : Apr 10, 26
Redburn Atlantic
Apr 2, 25
▲ Buy · 🎯$276
Price at call : $236.37 — upside +17%
Today : $336.54 — upside -18%
Expected +17% · Actual +16% · Reason (≥ +15%) : ✓ Yes
🎯 on LH : 100% (1 call matured) · 📊 unranked overall
+15.8%
stock +16% · XLV +2%
matured Apr 2, 26
▲ Buy · 🎯$300
Price at call : $256.81 — upside +17%
Today : $336.54 — upside -11%
Expected +17% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on LH : 100% (1 call matured) · 📊 on Health : 53.1% · +2.5% (508 calls)
+9.4%
stock +9% · XLV +6%
matured Mar 4, 26
Piper Sandler ↗
Feb 10, 25
■ Neutral neutral · not a buy · 🎯$260
Price at call : $245.14 — gap to target +6%
Today : $336.54 — gap to target -23%
🎯 on LH : no call matured yet · 📊 on Health : 46.7% · -1.3% (321 calls)
in progress (365j)
matures : Feb 10, 26
matures : Feb 10, 26
■ Equal-Weight neutral · not a buy · 🎯$260
Price at call : $245.08 — gap to target +6%
Today : $336.54 — gap to target -23%
🎯 on LH : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Feb 7, 26
matures : Feb 7, 26
▲ Buy · 🎯$290
Price at call : $246.27 — upside +18%
Today : $336.54 — upside -14%
Expected +18% · Actual +11% · Reason (≥ +15%) : ✗ No
🎯 on LH : 100% (2 calls matureds) · 📊 on Health : 50.8% · +4.5% (380 calls)
+11.3%
stock +11% · XLV +7%
matured Feb 7, 26
■ Equal-Weight neutral · not a buy · 🎯$271
Price at call : $246.67 — gap to target +10%
Today : $336.54 — gap to target -19%
🎯 on LH : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Feb 3, 26
matures : Feb 3, 26
▲ Buy · 🎯$286
Price at call : $246.22 — upside +16%
Today : $336.54 — upside -15%
Expected +16% · Actual +10% · Reason (≥ +15%) : ✗ No
🎯 on LH : 100% (3 calls matureds) · 📊 on Health : 51.5% · +3.1% (355 calls)
+9.6%
stock +10% · XLV +6%
matured Jan 28, 26
Evercore ISI Group ↗
Jan 7, 25
▲ Outperform · 🎯$265
Price at call : $234.31 — upside +13%
Today : $336.54 — upside -21%
Expected +13% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on LH : 100% (3 calls matureds) · 📊 on Health : 45.8% · +0.0% (168 calls)
+8.7%
stock +9% · XLV +13%
matured Jan 7, 26
Morgan Stanley ↗
Dec 17, 24
▲ Overweight · 🎯$270
Price at call : $226.31 — upside +19%
Today : $336.54 — upside -20%
Expected +19% · Actual +11% · Reason (≥ +15%) : ✗ No
🎯 on LH : 100% (3 calls matureds) · 📊 on Health : 51.5% · +5.2% (825 calls)
+11.4%
stock +11% · XLV +12%
matured Dec 17, 25
B of A Securities ↗
Dec 13, 24
▲ Buy · 🎯$271
Price at call : $229.62 — upside +18%
Today : $336.54 — upside -19%
Expected +18% · Actual +15% · Reason (≥ +15%) : ✗ No
🎯 on LH : 100% (2 calls matureds) · 📊 on Health : 48.3% · +2.0% (356 calls)
+14.7%
stock +15% · XLV +12%
matured Dec 13, 25
▲ Buy · 🎯$275
Price at call : $234.54 — upside +17%
Today : $336.54 — upside -18%
Expected +17% · Actual +12% · Reason (≥ +15%) : ✗ No
🎯 on LH : 100% (2 calls matureds) · 📊 on Health : 50.8% · +4.5% (380 calls)
+11.7%
stock +12% · XLV +6%
matured Dec 10, 25
▲ Buy
Actual +11% · Reason (≥ +15%) : ✗ No
🎯 on LH : 100% (1 call matured) · 📊 on Health : 53.6% · +1.4% (28 calls)
+11.3%
stock +11% · XLV -2%
matured Oct 30, 25
Piper Sandler ↗
Oct 28, 24
■ Neutral neutral · not a buy · 🎯$240
Price at call : $228.09 — gap to target +5%
Today : $336.54 — gap to target -29%
🎯 on LH : no call matured yet · 📊 on Health : 46.7% · -1.3% (321 calls)
in progress (365j)
matures : Oct 28, 25
matures : Oct 28, 25
■ Equal-Weight neutral · not a buy · 🎯$249
Price at call : $227.38 — gap to target +10%
Today : $336.54 — gap to target -26%
🎯 on LH : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Oct 25, 25
matures : Oct 25, 25
▲ Outperform · 🎯$289
Price at call : $228.63 — upside +26%
Today : $336.54 — upside -14%
Expected +26% · Actual +21% · Reason (≥ +15%) : ✓ Yes
🎯 on LH : 100% (3 calls matureds) · 📊 on Health : 51.7% · +6.5% (298 calls)
+20.6%
stock +21% · XLV -1%
matured Oct 25, 25
B of A Securities ↗
Aug 5, 24
▲ Buy · 🎯$260
Price at call : $225.87 — upside +15%
Today : $336.54 — upside -23%
Expected +15% · Actual +15% · Reason (≥ +15%) : ✓ Yes
🎯 on LH : 100% (2 calls matureds) · 📊 on Health : 48.3% · +2.0% (356 calls)
+15.5%
stock +15% · XLV -12%
matured Aug 5, 25
Deutsche Bank ↗
Aug 2, 24
■ Hold neutral · not a buy · 🎯$230
Price at call : $228.57 — gap to target +1%
Today : $336.54 — gap to target -32%
🎯 on LH : no call matured yet · 📊 on Health : 53.3% · +4.5% (291 calls)
in progress (365j)
matures : Aug 2, 25
matures : Aug 2, 25
Frequently asked questions
Should I buy Labcorp stock?
This isn't buy advice. For Labcorp, the analyst consensus is "Buy", with an average price target of $329 (-2% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (3 calls tracked on Labcorp). We show the numbers — you decide.
Is it too late to buy Labcorp? How high can it go?
The most bullish analyst target on Labcorp is $360 (+7% above today's price); the average is $329. That's the upside they see. Check how reliable those analysts have actually been on Labcorp on our site before trusting it.
Is Labcorp still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 20 analysts have a real record on Labcorp, the best hitting 100% over 3 calls. Current consensus: "Buy". Make your call on data, not noise.
Should you invest in Labcorp? The case for and against
The arguments for and against, one by one, from the numbers: why invest in LH (and why hesitate).
What has Labcorp's past performance been?
Historical returns and a "how much if I had invested" calculator: LH performance & returns.
Does Labcorp pay a dividend?
Yield, consistency and growth history of the dividend: LH's dividend.
BIIB 
VRTX 
UNH 
REGN 
EW 
SRPT 
VEEV 
BSX